These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6484049)

  • 21. Causes of iron overload.
    Bacon BR
    N Engl J Med; 1992 Jan; 326(2):126-7. PubMed ID: 1727219
    [No Abstract]   [Full Text] [Related]  

  • 22. False neurotransmitters and portal systemic encephalopathy.
    Payne JA
    Clin Neuropharmacol; 1982; 5(3):267-75. PubMed ID: 6126270
    [No Abstract]   [Full Text] [Related]  

  • 23. Initial experience with mesocaval H grafts: comparison with other portosystemic shunts.
    Bass A; Stoller M; Rosenman J; Adar R
    Isr J Med Sci; 1980; 16(9-10):684-5. PubMed ID: 6968744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemochromatosis].
    Simon M; Hespel JP; Brissot P; Fauchet R; Edan G; Le Reun M; Le Mignon L; Genetet B; Bourel M
    Ann Med Interne (Paris); 1981; 132(6):413-33. PubMed ID: 7032384
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic iron excess.
    Balcerzak SP
    Med Times; 1969 Jul; 97(7):114-29. PubMed ID: 5787906
    [No Abstract]   [Full Text] [Related]  

  • 26. Iron and liver: current concepts in the pathogenesis and management of chronic liver diseases.
    Guptan RC; Thakur V; Sarin SK
    J Assoc Physicians India; 1996 Mar; 44(3):198-202. PubMed ID: 9251318
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a porto-systemic shunt].
    Condat B; Dusoleil A; Bernardeau M; Roche A; Pelletier G; Buffet C
    Gastroenterol Clin Biol; 1999 Feb; 23(2):268-70. PubMed ID: 10353021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inose type hepatocerebral disease without cortical change--comparative and neuropathological discussion from the therapeutic point].
    Hori A; Nakamura T; Kishimoto H; Iwase S; Hozumi T
    Nagoya Med J; 1971 Mar; 16(4):225-46. PubMed ID: 5562104
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocerebral degeneration (portal systemic encephalopathy). The relationship to fatty acids.
    Asao H; Iwamoto S
    Wakayama Med Rep; 1965 Mar; 9(4):193-202. PubMed ID: 5824987
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of iron overload and hemochromatosis (author's transl)].
    Niederau C; Strohmeyer G
    Leber Magen Darm; 1981 Apr; 11(2):56-62. PubMed ID: 7015044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distal splenorenal shunt. 8 years' experience].
    Moreno González E; García Blanch G; de la Calle Santiuste A; Jelavic D; Landa García I; Rodríguez Agullo JL; Hidalgo Pascual M; Castellanos G; García García I; del Palacio A; Solozábal Pastor J; Pérez Mota A
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):1-17. PubMed ID: 6982490
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
    Kavitt RT; Yang VL; Jensen DM
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.
    Somberg KA; Riegler JL; LaBerge JM; Doherty-Simor MM; Bachetti P; Roberts JP; Lake JR
    Am J Gastroenterol; 1995 Apr; 90(4):549-55. PubMed ID: 7717309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of iron metabolism in patients with chronic hepatitis].
    Dorofeev GI; Tel'nykh IuV
    Klin Med (Mosk); 1984 May; 62(5):64-6. PubMed ID: 6748579
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment and prevention of chronic iron overload (author's transl)].
    Brissot P; Bourel M; Simon M
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1108-19. PubMed ID: 7319207
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome.
    Conn HO
    Hepatology; 1996 Jan; 23(1):177-81. PubMed ID: 8550038
    [No Abstract]   [Full Text] [Related]  

  • 37. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physiopathology and surgical treatment of hepatic encephalopathy after porto-caval anastomosis].
    Porcheron J; Balique JG
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):287-94. PubMed ID: 8572564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.
    McKay PJ; Murphy JA; Cameron S; Burnett AK; Campbell M; Tansey P; Franklin IM
    Bone Marrow Transplant; 1996 Jan; 17(1):63-6. PubMed ID: 8673057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mesocaval interposition shunt in the treatment of bleeding esophageal varices].
    Terpstra OT; van Vliet AC; van Urk H; Bruining HA; Wilson JH; van Vroonhoven TJ
    Ned Tijdschr Geneeskd; 1981 Jan; 125(4):144-9. PubMed ID: 6970899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.